Debt-free Balance SheetZero reported debt gives lasting financial flexibility: the company can fund working capital and inventory cycles without interest expense pressure, withstand demand shocks, and pursue opportunistic capex or M&A. This structural conservatism reduces solvency risk over a multi-month horizon.

Improving Revenue GrowthAn acceleration to roughly 12% top-line growth indicates durable demand or share gains for a distributor. Sustained revenue increases strengthen bargaining power with suppliers, enable scale-related operational improvements, and create a foundation for margin recovery and higher reinvestment capacity over the next several months.

Consistent Positive Free Cash FlowConsistent positive free cash flow supports self-funded growth, modest dividend payments, and balance sheet strengthening without new external financing. Over a 2–6 month horizon this underpins operational resilience and allows management to allocate cash to inventory, suppliers, or targeted investments as needed.

Bears Say

Very Thin Net MarginA structural net margin near 1% leaves little buffer against cost inflation or pricing pressure common in distribution. This limited profitability constrains retained earnings, restricts investment capacity, and makes long-term returns highly sensitive to small changes in selling prices or input costs.

Weakened Cash ConversionA drop in cash conversion to about 55% of net income signals working capital or timing strains; this reduces the real cash available to fund operations and investments despite positive earnings. Sustained weaker conversion would limit flexibility and heighten operational funding risk over coming months.

Inconsistent Operating Profit And ROE VolatilityVolatile EBIT and historically uneven ROE indicate earnings sensitivity to operating conditions. For a low-margin distributor this variability undermines planning and capital allocation, making future margin improvement and steady shareholder returns less predictable over a multi-month horizon.

9265 FAQ

What was YAMASHITA HEALTH CARE HOLDINGS, INC.’s price range in the past 12 months?

YAMASHITA HEALTH CARE HOLDINGS, INC. lowest stock price was ¥2361.00 and its highest was ¥3915.00 in the past 12 months.

What is YAMASHITA HEALTH CARE HOLDINGS, INC.’s market cap?

YAMASHITA HEALTH CARE HOLDINGS, INC.’s market cap is ¥9.10B.

When is YAMASHITA HEALTH CARE HOLDINGS, INC.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were YAMASHITA HEALTH CARE HOLDINGS, INC.’s earnings last quarter?

Currently, no data Available

Is YAMASHITA HEALTH CARE HOLDINGS, INC. overvalued?

According to Wall Street analysts YAMASHITA HEALTH CARE HOLDINGS, INC.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does YAMASHITA HEALTH CARE HOLDINGS, INC. pay dividends?

YAMASHITA HEALTH CARE HOLDINGS, INC. pays a Annually dividend of ¥61 which represents an annual dividend yield of 1.87%. See more information on YAMASHITA HEALTH CARE HOLDINGS, INC. dividends here

What is YAMASHITA HEALTH CARE HOLDINGS, INC.’s EPS estimate?

YAMASHITA HEALTH CARE HOLDINGS, INC.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does YAMASHITA HEALTH CARE HOLDINGS, INC. have?

YAMASHITA HEALTH CARE HOLDINGS, INC. has 2,553,000 shares outstanding.

What happened to YAMASHITA HEALTH CARE HOLDINGS, INC.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of YAMASHITA HEALTH CARE HOLDINGS, INC.?

Currently, no hedge funds are holding shares in JP:9265

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

YAMASHITA HEALTH CARE HOLDINGS, INC.

Yamashita Health Care Holdings,Inc. engages in the supply of medical equipment in Japan. The company offers diagnostic imaging devices, such as MRI and CT, endoscopic systems, operating tables, shadowless lights, and surgical equipment comprising electric scalpels, orthopedic implants, various catheters, and disposable medical materials; plans, manufactures, consigns, imports, and sells implants that are embedded in the body in the field of orthopedics; and sells and maintains medical equipment, which include dialysis machines/dialysis consumables, peritoneal dialysis, calculus crushing devices, and stents. It also provides consulting services related to the management of medical and long-term care institutions; and develops reservation solutions for hospitals consisting of search portal sites for hospitals and clinics, online reception, posting agency for customer satisfaction surveys, and network security systems sales. The company was founded in 1926 and is headquartered in Fukuoka City, Japan.